scholarly article | Q13442814 |
P356 | DOI | 10.3109/08830185.2010.498931 |
P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.3109/08830185.2010.498931 |
P698 | PubMed publication ID | 20839913 |
P2093 | author name string | Erhard Seifried | |
Erika Deak | |||
Reinhard Henschler | |||
P2860 | cites work | CCR7 and its ligands: balancing immunity and tolerance | Q24316090 |
Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone | Q28264546 | ||
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 | ||
Mesenchymal stem cells reside in virtually all post-natal organs and tissues | Q29617740 | ||
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 | Q29620590 | ||
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction | Q30477220 | ||
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia | Q33322707 | ||
Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner | Q33438830 | ||
Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis | Q33898618 | ||
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone | Q34066339 | ||
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects | Q35168236 | ||
Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta | Q35796570 | ||
Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment | Q35942343 | ||
Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 | Q80292406 | ||
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells | Q80413361 | ||
Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance | Q80641442 | ||
Transplanted mesenchymal stem cells are effective for skin regeneration in acute cutaneous wounds | Q80829971 | ||
Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2 | Q81393759 | ||
In search of the in vivo identity of mesenchymal stem cells | Q81485769 | ||
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients | Q81676895 | ||
Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults | Q83523597 | ||
The vessel wall and its interactions | Q36677300 | ||
Multipotent mesenchymal stromal cells and immune tolerance | Q36871706 | ||
Immunomodulatory properties of mesenchymal stromal cells | Q36896799 | ||
Mesenchymal stem cells: revisiting history, concepts, and assays. | Q37036368 | ||
Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. | Q37421286 | ||
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes | Q37492370 | ||
Mesenchymal stem cells for clinical application | Q37575905 | ||
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. | Q40085462 | ||
MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. | Q40188347 | ||
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells | Q40229749 | ||
Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation | Q40600413 | ||
Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation | Q40648302 | ||
Migration of mesenchymal stem cells to heart allografts during chronic rejection | Q40663512 | ||
Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment | Q41900619 | ||
Suspension medium influences interaction of mesenchymal stromal cells with endothelium and pulmonary toxicity after transplantation in mice | Q43237732 | ||
The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 | ||
Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation | Q44746492 | ||
Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation | Q45869865 | ||
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets | Q45882154 | ||
Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. | Q45983841 | ||
Galpha(s) uncouples hematopoietic stem cell homing and mobilization. | Q46019440 | ||
Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level | Q46978658 | ||
Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment | Q47273161 | ||
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. | Q47605121 | ||
Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type | Q47933679 | ||
Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds | Q48910075 | ||
In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions | Q48959085 | ||
Potential risks of bone marrow cell transplantation into infarcted hearts. | Q50685139 | ||
Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. | Q50963245 | ||
Human Cord Blood-Derived Mesenchymal Stem Cells Home and Survive in the Marrow of Immunodeficient Mice after Systemic Infusion | Q51016003 | ||
Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. | Q51116054 | ||
IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. | Q51677233 | ||
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. | Q51817034 | ||
Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. | Q53443788 | ||
Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. | Q53616452 | ||
Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. | Q53635005 | ||
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow | Q57601743 | ||
Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells | Q57702466 | ||
Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms | Q57805266 | ||
Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta | Q58789209 | ||
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury | Q58831554 | ||
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 | ||
Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice | Q64376329 | ||
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy | Q73358706 | ||
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates | Q78654754 | ||
Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture | Q78800357 | ||
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells | Q80077858 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 514-529 | |
P577 | publication date | 2010-10-01 | |
P1433 | published in | International Reviews of Immunology | Q6052764 |
P1476 | title | Homing pathways of mesenchymal stromal cells (MSCs) and their role in clinical applications | |
Homing Pathways of Mesenchymal Stromal Cells (MSCs) and Their Role in Clinical Applications | |||
P478 | volume | 29 |
Q34961598 | Bone marrow stromal cells as immunomodulators. A primer for dermatologists |
Q36936884 | Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma. |
Q39186262 | Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration. |
Q39265654 | Decidua mesenchymal stem cells migrated toward mammary tumors in vitro and in vivo affecting tumor growth and tumor development |
Q33900615 | Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells |
Q50276818 | Effects of diagnostic ultrasound-targeted microbubble destruction on the homing ability of bone marrow stromal cells to the kidney parenchyma. |
Q39175537 | Efficiency of systemic versus intralesional bone marrow-derived stem cells in regeneration of oral mucosa after induction of formocresol induced ulcers in dogs |
Q50437826 | Enhanced Homing Ability and Retention of Bone Marrow Stromal Cells to Diabetic Nephropathy by Microbubble-Mediated Diagnostic Ultrasound Irradiation. |
Q40271136 | Enhanced Homing of CXCR-4 Modified Bone Marrow-Derived Mesenchymal Stem Cells to Acute Kidney Injury Tissues by Micro-Bubble-Mediated Ultrasound Exposure |
Q30454160 | Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound |
Q46836604 | Factors enhancing the migration and the homing of mesenchymal stem cells in experimentally induced cardiotoxicity in rats. |
Q51536815 | Growth and positioning of adipose-derived stem cells in microfluidic devices. |
Q36506550 | Human umbilical cord matrix-derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets |
Q35975405 | Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects. |
Q28477068 | Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model |
Q36055845 | Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy |
Q37690626 | Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action |
Q26770191 | Mesenchymal stem cells and immunomodulation: current status and future prospects |
Q38113737 | Mountaineering pericytes--a universal key to tissue repair? |
Q38080483 | NK and MSCs crosstalk: the sense of immunomodulation and their sensitivity |
Q38107063 | Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. |
Q90267517 | Radiation-induced sensitivity of tissue-resident mesenchymal stem cells in the head and neck region |
Q35568777 | Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells |
Q50795417 | Stem cells and pulmonary fibrosis: cause or cure? |
Q33843839 | Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer |
Q35098108 | The effect of Kisspeptin-10 on mesenchymal stem cells migration in vitro and in vivo |
Q39160337 | The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy |
Q89737509 | Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges |
Q38181868 | Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases |
Search more.